Vall d'Hebron has participated in one of the clinical trials that have enabled the approval of the first specific pill for postpartum depression in the United States

by Vall d’Hebron

The United States has approved Zurzuvae, the first oral treatment specifically for postpartum depression, based on allopregnanolone, a neurosteroid created by the female sex hormone progesterone.

Read more
Subscribe to Directory
Write an Article

Recent News

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

New findings for a better understanding ...

by Universitat de Barcelona

A study published in Pediatric Neurology provides a better understandi...

Photos Stream